Studies of Neuregulin/ERBB Signaling in Human Heart

计划入组 80 人 · 首次发布于 2016 年 6 月 30 日

Maintaining ERBB Blockade in EGFR-mutated Lung Cancer

计划入组 4 人 · 首次发布于 2015 年 7 月 2 日

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Potential Anti-tumor Effects of SSGJ-705 in Patients With Advanced or Metastatic HER2-expressing Solid Tumors

计划入组 162 人 · 首次发布于 2021 年 12 月 6 日

Erbb2 inhibitors (Pfizer)

STI-A050X

CGT-1786

Erbe Elektromedizin GmbH

Germany

Puma Biotechnology Acquires Takeda's Aurora Kinase Inhibitor Alisertib for $7M Upfront

Salubris Bio's JK07 Shows Promise in Phase 2 Heart Failure Trial

Zenocutuzumab Achieves 30% Response Rate in NRG1 Fusion-Positive Solid Tumors, Receives FDA Approval